ÂÜÀòÂÒÂ×

Krishna Mohan Lakshmipathula is an experienced pharmaceutical professional with a focus on developing oral solid dosage forms. Currently serving as a Manager at Slayback Pharma since August 2021, Krishna Mohan leads F2F and 505B2 development initiatives. Prior experience includes a role as a Scientist at Dr. Reddy's Laboratories from February 2017 to August 2021, specializing in oral solid dosage forms for emerging markets, and a Research Associate position at Wockhardt Ltd. from November 2012 to January 2017, concentrating on generic development for US and Europe. Additionally, Krishna Mohan worked as a Research Executive at Orchid Healthcare from May 2010 to November 2012, focusing on generic development for the US market. Krishna Mohan holds a Master's degree in Pharmaceutical Sciences from Anna University of Technology, Tiruchirappalli - Ariyalur Campus, obtained in 2010.